PRTN3 and vasculitis: Our discovery cohort comprised 40 patients with systemic vasculitis (cohort 1), and emerged as part of investigation of expression of vasculitis-associated autoantigens (proteinase 3 (PR3), myeloperoxidase, and the associated alloantigen CD177).